<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000523318"><TermName>IgG-RFT5-dgA</TermName><TermDefinition><DefinitionText>A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of melanoma that has spread to distant parts of the body. IgG-RFT5-dgA is made in the laboratory. It can find and kill certain white blood cells that prevent the immune system from killing cancer cells. Also called RFT5-dgA immunotoxin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>IgG-RFT5-dgA</SpanishTermName><SpanishTermDefinition><DefinitionText>Anticuerpo monoclonal ligado a una sustancia tóxica. Está en estudio para el tratamiento del melanoma que se ha diseminado hasta partes distantes del cuerpo. La IgG-RFT5-dgA se produce en el laboratorio. Puede encontrar y destruir ciertos glóbulos blancos que impiden que el sistema inmunitario destruya las células cancerosas. También se llama inmunotoxina RFT5-dgA.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-12-01</DateFirstPublished><DateLastModified>2008-11-21</DateLastModified></GlossaryTerm>
